您的位置: 首页 > 农业专利 > 详情页

acetylcholine receptor agonist, compound, pharmaceutical composition, combination and use of alpha 7 nicotinic acetylcholine receptor activators
专利权人:
Novartis AG
发明人:
Baltazar Gomez-Mancilla,Dominik Feuerbach,Donald Johns,Therese Di Paolo
申请号:
BR112012006346
公开号:
BR112012006346A2
申请日:
2010.09.22
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
acetylcholine receptor agonist, compound, pharmaceutical composition, combination and use of alpha 7 ninotinic acetylcholine receptor activators The present invention relates to the use of an alpha 7 nicotinium acetylcholine receptor activator for the treatment, prevention or delay of the progression of dyskinesia associated with dopamine agonist therapy in parkinson's disease.agonista de receptor de acetilcolina, composto, composição farmacêutica, combinação e uso de ativadores de receptor de acetilcolina ninotínico alfa 7 a pres ente invenção se refere ao uso de um ativador de receptor acetilcolina nicotínio alfa 7 para o tratamento, prevenção ou atraso da progressõa da discinesia associada com a terapia com agonista de dopamina na doença de parkinson.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充